Treatment of anaphylactic reaction in pre-hospital and in the emergency room: literature review;Prise en charge d'une réaction anaphylactique en extrahospitalier et aux urgences : revue de la littérature

Annales Francaises d'Anesthesie et de Reanimation

Volumn 26, Issue 3, 2007, Pages 218-228

  Dewachter, P ^a   Mouton Faivre, C ^a   Nace, L ^a   Longrois, D ^a   Mertes, P M ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Anaphylaxis; Emergency medical services; Epinephrine; Hypersensitivity; Immediate

Indexed keywords

ADRENALIN; ANAHELP; ANAPEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; DRUG; SALBUTAMOL; TERBUTALINE; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR STIMULATING AGENT; ALLERGEN;

ANAPHYLAXIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FOOD; HUMAN; HYMENOPTERA; HYPERSENSITIVITY REACTION; IMMUNOLOGY; PREGNANCY; RATING SCALE; SHORT SURVEY; SYMPTOMATOLOGY; HOSPITALIZATION; REVIEW;

ADRENERGIC AGONISTS; ALLERGENS; ANAPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; EPINEPHRINE; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 33847674096     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2006.11.015     Document Type: Short Survey

References (72)

1. Société française d'anesthésie et de réanimation. Prévention du risque allergique peranesthésique. Recommandations pour la pratique clinique. Ann. Fr. Anesth. Reanim. 21 Suppl 1 (2002) 1-180
2. Johansson S., Hourihane J., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56 (2001) 813-824
3. Longrois D. Quel est le traitement de la réaction allergique survenant en cours d'anesthésie et en particulier du choc anaphylactique ?. Ann. Fr. Anesth. Reanim. 21 Suppl 1 (2002) 168-180
4. Dewachter P., Jouan-Hureaux V., Franck P., Menu P., de Talancé N., Zannad F., et al. Anaphylactic shock: a form of distributive shock without inhibition of oxygen consumption. Anesthesiology 103 (2005) 40-49
5. The International Collaborative Study of Severe Anaphylaxis. An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology 9 (1998) 141-146
6. Helbling A., Humi T., Mueller U.R., and Pichler W.J. Incidence of anaphylaxis with circulatory symptoms: A study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern. Clin. Exp. Allergy 34 (2004) 285-290
7. Sampson H.A., Munoz-Furlong A., Bock S.A., Schmitt C., Bass R., Chowdhury B.A., et al. Symposium on the Definition and Management of Anaphylaxis: Summary Report. J. Allergy Clin. Immunol. 115 (2005) 584-591
8. Moneret-Vautrin D., Morisset M., Flabbee J., Beaudoin E., and Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 60 (2005) 443-451
9. Neugut A., Ghatak A., and Miller R. Anaphylaxis in the United States: An investigation into its epidemiology. Arch. Intern. Med. 161 (2001) 15-21
10. Pumphrey R., and Stanworth S. The clinical spectrum of anaphylaxis in north-west England. Clin. Exp. Allergy 26 (1996) 1364-1370
11. Sheikh A., and Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 320 (2000) 1441
12. Mullins R. Anaphylaxis: risk factors for recurrence. Clin. Exp. Allergy 33 (2003) 1033-1040
13. Fernandez J., Blanca M., Soriano V., Sanchez J., and Juarez C. Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area. Clin. Exp. Allergy 29 (1999) 1069-1074
14. Sampson H., Mendelson L., and Rosen J. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N. Engl. J. Med. 327 (1992) 380-384
15. Kanny G., Moneret-Vautrin D., Flabbee J., Beaudoin E., Morisset M., and Thevenin F. Population study of food allergy in France. J. Allergy Clin. Immunol. 108 (2001) 133-140
16. Yocum M., Butterfield J., Klein J., Volcheck G., Schroeder D., and Silverstein M. Epidemiology of anaphylaxis in Olmsted County: A population-based study. J. Allergy Clin. Immunol. 104 (1999) 452-456
17. Certin A. Choc anaphylactique en médecine pré-hospitalière : étude rétrospective (1993-1997). Thèse de Médecine, Poitiers 1998.
18. Practice Parameters of the Joint Task Force on Practice Parameters for Allergy and Immunology. Stinging insect hypersensitivity: A Practice Parameter Update. J. Allergy Clin. Immunol. 114 (2004) 869-886
19. Pumphrey R. Lessons for management of anaphylaxis from a study of fatal reactions. Clin. Exp. Allergy 30 (2000) 1144-1150
20. Charpin D., Birnbaum J., and Vervloet D. Epidemiology of hymenoptera allergy. Clin. Exp. Allergy 24 (1994) 1010-1015
21. Practice Parameters of the Joint Task Force on Practice Parameters for Allergy and Immunology. The diagnosis and management of anaphylaxis: An Updated Practice Parameter. J. Allergy Clin. Immunol. 115 (2005) S483-S523
22. Freeman T.M. Hypersensitivity to Hymenoptera Stings. N. Engl. J. Med. 351 (2004) 1978-1984
23. Brasher G.W., and Sanchez S.A. Reversible electrocardiographic changes associated with wasp sting anaphylaxis. JAMA 229 (1974) 1210-1211
24. Wegmann A., and Renker H. Electrocardiogramme in anaphylactic shock in humans. Klin. Wochenschr. 54 (1976) 453-459
25. Assem E.S. Anaphylactic reactions affecting the human heart. Agents Actions 27 (1989) 142-145
26. Moneret-Vautrin D.A., Kanny G., Faller J.P., Levan D., and Kohler C. Severe anaphylactic shock with heart arrest caused by coffee and gum arabic potentiated by β-blocking eyedrops. Rev. Med. Interne 14 (1993) 107-111
27. Attenhofer C., Speich R., Salomon F., Burkhard R., and Amann F.W. Ventricular fibrillation in a patient with exercise-induced anaphylaxis, normal coronary arteries, and a positive ergonovine test. Chest 105 (1994) 620-622
28. Stark B.J., and Sullivan T.J. Biphasic and protracted anaphylaxis. J. Allergy Clin. Immunol. 78 (1986) 76-83
29. Brazil E., and Mac Namara A.F. Not so immediate" hypersensitivity-the danger of biphasic anaphylactic reactions. J. Accid. Emerg. Med. 15 (1998) 252-253
30. Journal Officiel de la République Française. Décret 95-278 relatif à la pharmacovigilance. 1995.
31. Kaplan A.P., and Greaves M.W. Angioedema. J. Am. Acad. Dermatol. 53 (2005) 373-388
32. American Heart Association. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 10.6: Anaphylaxis. Circulation 112 (2005) (IV-143-IV-145)
33. Ring J., and Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet i (1977) 466-469
34. Mertes P.M., Laxenaire M., Alla F., and et le Groupe d'études des réactions anaphylactoïdes peranesthésiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 99 (2003) 536-545
35. Mertes P.M., Laxenaire M.C., and et le Groupe d'études des réactions anaphylactoïdes peranesthésiques. Épidémiologie des réactions anaphylactiques et anaphylactoïdes peranesthésiques en France. Septième enquête multicentrique (Janvier 2001-Décembre 2002). Ann. Fr. Anesth. Reanim. 23 (2004) 1133-1143
36. Clément O. Produits de contraste : la prémédication systématique doit disparaître. J. Radiol. 84 (2003) 531
37. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 8: Advanced challenges in resuscitation. Section 3: Special challenges in ECC. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 102 (2000) (I-229-I-252)
38. Johnston S., Unsworth J., and Gompels M. Adrenaline given outside the context of life threatening allergic reactions. BMJ 326 (2003) 589-590
39. Mc Govern S.J. Treatment of accidental digital injection of adrenaline from an autoinjector device. J. Accid. Emerg. Med. 14 (1997) 379-380
40. Murali K.S., and Nayeem N. Accidental digital injection of adrenaline from an autoinjector device. J. Accid. Emerg. Med. 15 (1998) 287
41. Barkhodarian A.R., Wakelin S.H., and Paes T.R. Accidental digital injection of adrenaline from an autoinjector device. Br. J. Dermatol. 143 (2000) 1359
42. Schintler M.V., Arbab E., Aberer W., Spendel S., and Scharnagl E. Accidental perforating bone injury using the Epipen autoinjection device. Allergy 60 (2005) 259
43. Simons F.E.R., Roberts J.R., Gu X., and Simons K.J. Epinephrine absorption in children with a history of anaphylaxis. J. Allergy Clin. Immunol. 101 (1998) 33-37
44. Simons F.E.R., Gu X., and Simons K.J. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J. Allergy Clin. Immunol. 108 (2001) 871-873
45. Pumphrey R. Fatal posture in anaphylactic shock. J. Allergy Clin. Immunol. 112 (2003) 451-452
46. Pumphrey R. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found. Symp. 257 (2004) 116-132
47. Horowitz B., Jadallah S., and Derlet R. Fatal intracranial bleeding associated with prehospital use of epinephrine. Ann. Emerg. Med. 28 (1996) 725-727
48. Dewachter P., Mouton-Faivre C., Pertek J.P., Boudaa C., and Mertes P.M. Intérêt des tests cutanés pour le choix d'un curare après une réaction anaphylactique. Ann. Fr. Anesth. Reanim. 24 (2005) 543-546
49. Fisher M.M. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth. Intensive Care 14 (1986) 17-21
50. Sadana A., O'Donnell C., Hunt M.T., and Gavalas M. Managing acute anaphylaxis. Intravenous adrenaline should be considered because of the urgency of the condition. BMJ 320 (2000) 937
51. American Heart Association. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 7.2: Management of Cardiac Arrest. Circulation 112 (2005) (IV-58-IV-66)
52. American Heart Association. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 4: Adult Basic Life Support. Circulation 112 (2005) IV19-IV34
53. Higgins D.J., and Gayatri P. Methoxamine in the management of severe anaphylaxis. Anaesthesia 54 (1999) 1110-1129
54. McBrien M.E., Breslin D.S., Atkinson S., and Johnston J.R. Use of methoxamine in the resuscitation of epinephrine-resistant electromechanical dissociation. Anaesthesia 56 (2001) 1082-1089
55. Heytman M., and Rainbird A. Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review. Anaesthesia 59 (2004) 1210-1215
56. Landry D.W., Levin H.R., Gallant E.M., Seo S., D'Alessandro D., Oz M.C., et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit. Care Med. 25 (1997) 1279-1282
57. Malay M.B., Ashton R.C., Landry D.W., and Townsend R.N. Low-Dose Vasopressin in the Treatment of Vasodilatory Septic Shock. J. Trauma 47 (1999) 699-705
58. Patel B.M., Chittock D.R., Russell J.A., and Walley K.R. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96 (2002) 576-582
59. Dünser M.W., Mayr A.J., Ulmer H., Knotzer H., Summan G., Pajk W., et al. Arginine vasopressin in advanced vasodilatory shock. A prospective randomized controlled study. Circulation 107 (2003) 2313-2319
60. O'Brien A., Clapp L., and Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 359 (2002) 1209-1210
61. Jolley D.H., de Keulenaer B.L., Potter A., and Stephens D.P. Terlipressin infusion in catecholamine-resistant shock. Anaesth. Intensive Care 31 (2003) 560-564
62. Leone M., Albanèse J., Delmas A., Chaabane W., Garnier F., and Martin C. Terlipressin in catecholamine-resistant septic shock patients. Shock 22 (2004) 314-319
63. Kill C., Wranze E., and Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Int. Arch. Allergy Immunol. 134 (2004) 260-261
64. Schummer W., Schummer C., Wippermann J., and Fuchs J. Anaphylactic shock: is vasopressin the drug of choice?. Anesthesiology 101 (2004) 1025-1027
65. Williams S.R., Denault A.Y., Pellerin M., and Martineau R. Vasopressin for treatment of shock following aprotinin administration. Can. J. Anesth. 51 (2004) 169-172
66. Dewachter P., Jouan-Hureaux V., Lartaud I., Bello G., de Talancé N., Longrois D., et al. A comparison of arginine vasopressin, terlipressin or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized Brown Norway rats. Anesthesiology 104 (2006) 734-741
67. L'Her E. Révision de la troisième conférence de consensus en réanimation et médecine d'urgence de 1988 : Prise en charge des crises d'asthme aiguës graves de l'adulte et de l'enfant (à l'exclusion du nourrisson). Réanimation 11 (2002) 1-9
68. Laxenaire M.C., Charpentier C., and Feldman L. Réactions anaphylactoïdes aux substituts colloïdaux du plasma : incidence, facteurs de risque, mécanismes. Enquête prospective multicentrique française. Ann. Fr. Anesth. Reanim. 13 (1994) 301-310
69. Recommandations pour la Pratique Clinique. Remplissage vasculaire au cours de hypovolémies relatives ou absolues. Quels sont les éléments du choix des produits de remplissage et leur stratégie d'utilisation ?. Réan Urg 6 (1997) 389-405
70. Lee R., Rodgers B., White L., and Harvey R. Cardiopulmonary resuscitation of pregnant women. Am. J. Med. 81 (1986) 311-318
71. Marx G. Cardiopulmonary resuscitation of the late pregnant woman. Anesthesiology 56 (1982) 156
72. American Heart Association. Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 10.8: Cardiac arrest associated with pregnancy. Circulation 112 (2005) IV150-IVIV3